Inkcazo yeLexapro yeNgxaki yokuxhalabisa abantu

I-Lexapro (escitalopram) yi- serotonin i-reuptake inhibitor (SSRI) ekhethiweyo evunyiweyo yi-Food and Drug Administration (FDA) yokunyangwa koxinzelelo kunye nengxaki yokuxhalabisa ngokubanzi (GAD). Nangona iLexapro ayivunyelwanga yi-FDA yokunyangwa kwengxaki yokuxhalaba kwezenhlalakahle (SAD), kuthathwa njengelungele ukonyango kwale meko kwaye idlalwa ngoogqirha.

Ukuphumelela kweLexapro kwiNgxaki yokuXhalabisa kweNtlalo

Uphando luye lwabonisa ngokuphindaphindiweyo ukuba iLexapro iphumelele ekuphatheni ingxaki yokuxhalabisa abantu. I-Association of Adxiety and Depress of America (ADAA) dwelisa i-Lexapro (escitalopram) njengonyango lokuqala lwezonyango kwi-SAD, kunye neCelexa (citalopram), i-Viibryd (vilazodone), kunye namachiza avunyelwe yi-FDA ekuphatheni i-SAD, i-Paxil (i-paroxetine), ukukhululwa ngokukhawuleza kunye nokulawulwa okulawulwayo, iZoloft (sertraline), ukukhululwa kwe-Luvox (fluvoxamine) okulawulwayo, kunye ne-Effexor (venlafaxine) inokukhululwa.

Indlela yokuthatha iLexapro

I-Lexapro inokuthi ithathe iipilisi okanye isisombululo somlomo rhoqo ngosuku, kusasa okanye kusihlwa, kunye okanye ngaphandle kokutya.

Izikhokelo zeNqanaba

Isiqhelo esiphezulu somyinge weLexapro singama-10 mg, kodwa ugqirha wakho angaqala kwiqondo eliphantsi. Umyinge unokunyuka ufike kwi-20 mg okanye ngaphezulu xa kufuneka. Kungathatha nantoni na ukuya kwiiveki ezine ukuba uzive ungcono xa uqala ukuthatha iLexapro.

Ngubani ongafanelanga ukuthatha iLexapro

Akufanele uthabathe iLexapro ukuba u-hypersensitive kwi-escitalopram oxalate. Ukusebenza kweLexapro ukusetyenziswa kunye nabantwana abaneminyaka engaphantsi kweminyaka eyi-18 ayinakusungulwa kwaye ayinyanzeliswa ngokubanzi kubantwana abangaphantsi kweminyaka eyi-12.

Ulwalamano lweMithi

I-Lexapro ayifanele idibaniswe ne-monoamine oxidase inhibitors (MAOIs), kwaye isetyenziswe kuphela nge-tryptophan, ezinye ii-SSRI, i-serotonin-norepinephrine reuptake inhibitors (i-SNRIs), ne-St.

Igosa likaJohane ngokulumkisa nokuvavanya ngokuthe ngqo ngenxa ye-serotonin syndrome.

Sebenzisa i-Lexapro ngokuqaphela ukuba ukhulelwe okanye uncelisayo.

Tshela ugqirha wakho malunga nayiphi na imithi kunye neyeza-anti-counter-therapy ezithathayo, ingakumbi ukuba uthatha i-aspirin, i-warfarin, amayeza okuthintela, ukuxhalaba, ukuxinezeleka, okanye i-migraines, okanye izidakamizwa ezichasene nezidakamizwa (i-NSAID) ezifana Motrin (ibuprofen) okanye iAleve (naproxen).

Imiphumela

Imiphumo echaphazelekayo yokuthatha iLexapro iquka:

Ngokuqhelekileyo, iimiphumo ziya kuhamba emva kwexesha elifutshane, kodwa ukuba azinako okanye zinzima, vumela ugqirha wakho azi.

Ukuba unemiphumo emibi efana nokuziva unomdla, ungenayo ifilosofi, okanye unomkhuhlane, ukujuluka, izihlunu ezinzima, ukudideka, kunye nentliziyo yakho ngokukhawuleza, qiniseka ukubiza ugqirha wakho ngokukhawuleza.

Mngcipheko

Ukusebenzisa iLexapro kunokuthatha ingozi, kubandakanyeka ukunyuka kweekliniki, ingozi eyingozi yokuzibulala nokuziphatha, ngakumbi kubantu abatsha, i- serotonin syndrome , kunye neempembelelo zokuhoxiswa.

Ukuvavanya ukuvavanywa ngongqondo wakho okanye ugqirha kubalulekile.

Ukuba unqunywe lonyango ngugqirha wakho, qiniseka ukuba ulandela imiyalelo ngokucophelela. Ukuba unemibuzo eyongezelelweyo, oku kuphendulwa bhetele ngunyango lwezonyango.

> Imithombo:

> Ukuxhalabisa kunye neNkxwaleko yokuThuthukiswa kweMelika (ADAA). Ukuhlaziywa kweeNtsholongwane zeCandelo loKhathazeka kweNtlalo. Ishicilelwe ngoSeptemba 15, 2015.

> Baldwin DS, Asakura S, Koyama T, et al. Ukusebenza kwe-Escitalopram kwi-Treatment of Social Discouragement Disorder: i-Meta-Analysis Versus Placebo. European Neuropsychopharmacology . NgoJuni 2016; 26 (6): 1062-1069. i-doi: 10.1016 / j.euroneuro.2016.02.013.

> Medline Plus. Escitalopram. ILayibrari yeSizwe ka-US yamayeza. Ukuhlaziywa ngoFebruwari 15, 2016.